Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines

[1]  R. Webster,et al.  Generation of High-Yielding Influenza A Viruses in African Green Monkey Kidney (Vero) Cells by Reverse Genetics , 2004, Journal of Virology.

[2]  Marion Koopmans,et al.  Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Webster,et al.  Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. , 2003, Virology.

[4]  D. Fedson.  Pandemic influenza and the global vaccine supply. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  N. Cox,et al.  Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. , 2003, Virology.

[6]  R. Webster,et al.  Eight-plasmid system for rapid generation of influenza virus vaccines. , 2002, Vaccine.

[7]  J. Treanor,et al.  Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. , 2002, Vaccine.

[8]  A. García-Sastre,et al.  Plasmid-only rescue of influenza A virus vaccine candidates. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[9]  J. Wood.  Developing vaccines against pandemic influenza. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[10]  R. Webster,et al.  A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Y. Guan,et al.  Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. , 2000, Veterinary microbiology.

[12]  A. García-Sastre,et al.  Rescue of influenza A virus from recombinant DNA. , 2007, Journal of virology.

[13]  Tokiko Watanabe,et al.  Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Subbarao,et al.  Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. , 1999, The Journal of infectious diseases.

[15]  A. Palache,et al.  Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine. , 1999, Developments in biological standardization.

[16]  F. Dorner,et al.  Development of a Vero cell-derived influenza whole virus vaccine. , 1999, Developments in biological standardization.

[17]  Y. Guan,et al.  Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. , 1998, Virology.

[18]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.

[19]  R. Webster,et al.  A pandemic warning? , 1997, Nature.

[20]  R. Webster,et al.  Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. , 1987, Virology.

[21]  H. Klenk,et al.  Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses. , 1981, Virology.

[22]  H. Klenk,et al.  The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. , 1979, Virology.

[23]  E. D. Kilbourne.  Future influenza vaccines and the use of genetic recombinants. , 1969, Bulletin of the World Health Organization.